Submit Your Article

Journal of Immunology Research and Infectious Diseases

  1. Journal Home
  2. Author Guidelines

Authors' Guidelines

The Journal of Journal of Immunology Research and Infectious Diseases (JIRID) invites high-quality submissions that advance understanding and innovation in virology, immunology, and vaccine research. We welcome a wide range of manuscript types, including original research articles, clinical trials, systematic reviews, brief reports, technical notes, case studies, perspectives, and letters to the editor.

Manuscripts must be submitted via our online submission system. In case of technical difficulties, submissions can be emailed to: editor.JIRID@acadwise.com.

The corresponding author serves as the main point of contact throughout the review and publication process and is responsible for the accuracy and integrity of the submission.

By submitting a manuscript, authors affirm that:

  • The work is original, unpublished, and not under consideration elsewhere.
  • All authors have reviewed and approved the final version.
  • All applicable ethical standards and institutional approvals have been met.

2.1 General Formatting

  • Font: Times New Roman, 12 pt
  • Line spacing: Double-spaced
  • File format: Word (.doc/.docx) or PDF
  • Page numbering: Consecutive, bottom right corner

2.2 Required Sections

Each manuscript should include the following components in order:

  • Cover Letter
  • Title Page
    • Full title of the manuscript
    • Full names, affiliations, and email addresses of all authors
    • Contact details for the corresponding author
  • Abstract
    • A concise summary (150–250 words) outlining objectives, methods, key results, and conclusions
  • Keywords
    • 4–6 relevant terms for indexing

Main Text Structure:

For original research articles:

  • Introduction
  • Methods
  • Results
  • Discussion
  • Conclusion

Other article types (e.g., reviews, brief reports) may follow alternative structures appropriate to their format.

  • Acknowledgments (if applicable)
  • Conflict of Interest Disclosure
  • Funding Statement
  • References
    • Use Vancouver style; list references numerically in the order cited.
    • Include all authors unless there are more than six, in which case list the first six followed by et al.
  • Figures and Tables
    • Figures: High-resolution, submitted as JPEG or PNG files
    • Tables: Editable Word format (do not embed as images)
  • Supplementary Material

Submit any appendices, datasets, or additional files separately

Journal of Immunology Research and Infectious Diseases
ISSN Online: 2771-3083
Email: editor.jirid@acadwise.com

The Journal of Immunology Research and Infectious Diseases (JIRID) publishes original and high-impact research that advances understanding in immunology, host-pathogen interactions, infectious diseases, immune system disorders, and related therapeutic innovations. We accept a broad range of manuscript types that reflect the depth and diversity of immunological and infectious disease research.

All submissions must comply with ethical publishing practices guided by the Committee on Publication Ethics (COPE). This includes proper ethical approvals, informed consent where applicable, and full disclosure of conflicts of interest and funding sources.

1. Original Research Article

Reports of novel and scientifically sound experimental or clinical findings in immunology or infectious diseases.
Structure:
• Abstract
• Keywords
• Introduction
• Materials and Methods
• Results
• Discussion
• Conclusion

2. Review Article

Comprehensive and critical evaluations of existing literature on key topics. Should highlight gaps, controversies, and potential research directions.

3. Systematic Review

Structured reviews that follow defined methodologies to answer specific scientific or clinical questions. Must follow PRISMA guidelines and be registered (e.g., PROSPERO).
Must include:
• Search strategy
• Selection criteria
• Risk of bias assessment
• PRISMA flow diagram

4. Brief Report

Concise articles reporting impactful preliminary data or pilot studies in immunology or infectious disease surveillance.

5. Case Report

Thorough documentation of rare or insightful clinical cases related to immunological disorders, infections, or unusual presentations. Requires patient consent.
Structure:
• Abstract
• Keywords
• Introduction
• Case Description
• Discussion
• Conclusion

6. Case Series

Grouped case presentations demonstrating patterns, clinical variations, or outcomes within a specific disease or treatment context.

7. Clinical Trial Report

Results of interventional or observational studies. Must follow CONSORT guidelines and include trial registration details.

8. Hypothesis

Presentation of novel scientific hypotheses with theoretical or preliminary data justification relevant to immunology or infectious diseases.

9. Protocol

Peer-reviewed descriptions of planned or ongoing studies (e.g., vaccine trials, diagnostic development, immune response profiling). Registration is strongly encouraged.

10. Registered Report

Study design evaluated and peer-reviewed prior to data collection. Promotes research transparency and minimizes outcome bias.

11. Communication

Rapid dissemination of important or urgent findings with immediate relevance to the research or clinical community.

12. Perspective

Forward-looking pieces exploring innovations, future challenges, or policy implications in immunology and infectious diseases.

13. Opinion

Evidence-based commentaries or viewpoints on emerging issues or controversies in the field. Clearly marked as opinion.

14. Commentary

Scholarly discussion or critique of a recently published article.
Structure:
• Title
• Abstract (~150 words, unstructured)
• Keywords
• Main Text
• References

15. Editorial

Written by editors or invited experts, editorials explore current developments, thematic issues, or policy implications. No original research data.

16. Technical Note

Descriptions of new techniques, methodologies, or diagnostic tools in immunological or infectious disease research. Must be replicable.

17. Visual Case / Image in Immunology

High-resolution visual content (e.g., histology, flow cytometry, clinical images) with educational or diagnostic value. Requires patient consent if identifiable.

18. Abstract / Proceedings Paper

Conference-derived content such as abstracts or expanded summaries of oral/poster presentations. Source event must be cited.

19. Conference Report

Summarized insights from conferences, symposia, or workshops. Must distinguish between objective reporting and author interpretation.

20. Book Review

Analytical reviews of recent publications relevant to immunology, microbiology, or infectious diseases. Must disclose potential conflicts.

21. Mini Review

Short, focused literature reviews on emerging or narrow topics. Ideal for fast-moving research areas.
Structure:
• Abstract
• Keywords
• Introduction
• Main Content
• Optional Discussion
• References

Ethical Requirements for All Article Types

To ensure integrity and accountability, all submissions to JIRID must meet the following ethical standards:

  • Ethics committee approval and informed consent when applicable
  • Transparency in data collection, funding, and authorship
  • Avoidance of plagiarism, duplicate submission, and data manipulation
  • Disclosure of conflicts of interest
  • Willingness to correct the record through retractions, corrections, or notices per COPE recommendations

For inquiries or to submit your manuscript, contact us at:
editor.jirid@acadwise.com
We invite your contributions to help advance scientific and clinical understanding in immunology and infectious diseases.

All submissions undergo rigorous double-blind peer review, ensuring the anonymity of both authors and reviewers. Manuscripts are assessed on originality, scientific rigor, clarity, and relevance to JIRID’s scope. Authors may recommend reviewers, but final selection is at the editors’ discretion.

JIRID follows a gold open-access model, ensuring free access to all published content. An Article Processing Charge (APC) applies upon acceptance. Full fee details are available on our website.

We offer APC waivers or discounts for authors from low-income countries and for those without research funding; requests can be submitted during the submission process.

Upon acceptance, authors agree to transfer copyright to JIRID. Published articles are licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), allowing non-commercial reuse with appropriate attribution.

Authors must adhere to the highest standards of research integrity. Where applicable:

  • Provide details of ethical approval for studies involving humans or animals
  • Ensure datasets are made publicly available or accessible upon request
  • Describe methods thoroughly to enable replication

Authors are expected to promptly inform the editorial office of any errors or inaccuracies identified after publication. Corrections, retractions, or notices will be issued in line with COPE (Committee on Publication Ethics) guidelines.

Submitting a manuscript or withdrawing is solely the interest of an author and we respect their decision. Withdrawal of a manuscript will be permitted only for the most unavoidable reasons, as it wastes the valuable resources and tremendous amount of effort made in processing the manuscripts by the editors, reviewers and the editorial staff.

Authors are entitled to change their mind regarding submitting or withdrawing their articles and they can withdraw their article at no charge - if withdrawn within 3 days of its initial submission only. If the author(s) requests a withdrawal of manuscript any time after the peer review process or in the production stage (Early release) or after it is published online- they will be subjected to payment of 60% of the original article processing fee.

For full submission instructions, templates, and access to the submission portal, please visit our website or contact us at: editor.JIRID@acadwise.com.